Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Frazer, Henry A. Pharm D
WARNING LETTER
•Frazer, Henry A. Pharm D•October 3, 2012

Frazer, Henry A. Pharm D – FDA Warning Letter, Oct 3, 2012

Record Details

This FDA Warning Letter, dated June 5, 2013, addresses objectionable conditions observed during an inspection of Dr. Henry A. Frazer's clinical site from September 24 to October 3, 2012. The inspection, part of FDA's Bioresearch Monitoring Program, reviewed Dr. Frazer's conduct of two clinical investigations for investigational drugs, Protocols (b)(4) and (b)(4).

The letter identifies two primary violations:

1. **Failure to ensure investigation was conducted according to the investigational plan [21 CFR 312.60]:** * **Protocol (b)(4) violations:** * Subject 09-006 was not dispensed a LogPad as required, and five pain assessments were entered by the study coordinator, not the subject, compromising data validity. Dr. Frazer's response acknowledged this but lacked a corrective action plan. * Subject 09-006 did not meet eligibility criteria (ASA Physical Status Classification of 4 instead of 1-3, and QTc interval of 453ms instead of <450ms), jeopardizing subject safety and data integrity. Dr. Frazer failed to respond to this item or provide a corrective action plan. * Prohibited pain medications (Percocet, oxycodone) were administered to Subjects 31-

Company
Frazer, Henry A. Pharm D
Inspection date
October 3, 2012
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas N. Moreno
View Company Profile

ID · 816a19d2-813d-4013-b412-451222c3e32b

Violation Codes2
21 CFR 312.6021 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Frazer, Henry A. Pharm D
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.